The joining of Okazaki fragments during lagging strand DNA replication in mammalian cells is believed to be due to DNA ligase I. This enzyme is composed of a 78-kDa carboxyl-terminal catalytic domain and a 24-kDa amino-terminal region that is not required for ligation activity in vitro. Extracts of the human cell line 46BR.1G1, in which DNA ligase I is mutationally altered, supported aberrant in vitro SV40 DNA replication; the joining of Okazaki fragments was defective, and unligated intermediates were unstable. Human DNA ligase I, but not DNA ligase III or bacteriophage T4 DNA ligase, complemented both defects in 46BR.1G1 extracts. The catalytic domain of DNA ligase I was 10-fold less effective in complementation experiments than the fulllength protein, indicating that the amino-terminal region of the enzyme is required for efficient lagging strand DNA replication. Moreover, in vitro SV40 DNA replication in normal human cell extracts was inhibited by an excess of either full-length DNA ligase I or the amino-terminal region of the protein, but not by the catalytic domain. This inhibition may be mediated by the interaction of the amino-terminal region of DNA ligase I with other replication proteins.Several distinct DNA ligases have been identified in mammalian cells, DNA ligase I being a major activity in proliferating cells (1, 2). Cytostaining experiments with antibodies against DNA ligase I showed that the enzyme is specifically localized in the nucleus with the same granular staining pattern as DNA polymerase ␣, implicating DNA ligase I in DNA replication (3). DNA ligase I (in conjunction with DNA polymerase ␣, ␦, or ⑀; RNase H1; and the 5Ј-nuclease DNase IV/ FEN-1) is able to complete lagging strand DNA replication in vitro on a synthetic DNA substrate (4), and DNA ligase I activity also functions to generate closed circular DNA during SV40 DNA replication reconstituted with SV40 large T antigen and purified mammalian proteins (5, 6).The human DNA ligase I cDNA encodes a 102-kDa polypeptide (7). A 78-kDa carboxyl-terminal domain shows significant amino acid sequence homology to the CDC9 and cdc17 ϩ gene products of Saccharomyces cerevisiae and Schizosaccharomyces pombe as well as to the human DNA ligase III and IV cDNAs. This domain is catalytically active in vitro in the absence of the amino-terminal region and is able to complement a conditional/ lethal DNA ligase mutant of Escherichia coli (8). The 24-kDa amino-terminal portion of human DNA ligase I is a proteasesensitive hydrophilic region that has no counterpart in other mammalian DNA ligases or the yeast DNA ligases. Although this amino-terminal region is not required for activity of DNA ligase I in standard in vitro DNA joining assays, it is essential in vivo to counteract the lethal effect of knocking out DNA ligase I in mouse embryonic stem cells by the ectopic expression of DNA ligase I (9). A functional role for the amino-terminal portion of DNA ligase I during DNA replication has not been directly demonstrated, but this region may serve to locali...